Nov 04, 2024
FEDERAL CONTRACEPTION PROPOSAL TO EXPAND ACCESS AND AFFORDABLE COVERAGE PAVES A STRONGER PATH FOR MAYNE PHARMA'S GROWTH IN WOMEN'S HEALTH
Jul 27, 2020
Mayne Pharma Launches Chlorzoxazone Tablet in the United States
Jun 24, 2020
Mayne Pharma Announces FDA Filing Acceptance of New Drug Application for E4/DRSP in the US
May 22, 2020
Mayne Pharma launches BAC 300 capsules in the United States
Apr 16, 2020
Mayne Pharma Submits New Drug Application for E4/DRSP to the FDA
Oct 02, 2019
Mayne Pharma Signs 20-Year Exclusive License and Supply Agreement for Novel Oral Contraceptive in the US
May 22, 2019
FDA Approves SORILUX(R) for Adolescent Plaque Psoriasis
Apr 30, 2019
FDA approves trade name Lexette(TM) (halobetasol propionate) foam, 0.05%
Feb 13, 2019
Mayne Pharma launches Lexette (TM) (halobetasol propionate) foam 0.05% in the United States
Jan 30, 2019
TOLSURA (TM) (SUBA®-itraconazole) Antifungal Capsule Now Available in the United States
Dec 17, 2018
HedgePath Pharmaceuticals and Mayne Pharma Enter into Updated Collaboration and Funding Agreements
Dec 11, 2018
Mayne Pharma receives FDA approval of Tolsura(TM) (SUBA®-itraconazole capsules) for the treatment of certain fungal infections
Nov 12, 2018
Metrics Contract Services Announces Serialization Capabilities at Greenville Site
Nov 01, 2018
Metrics Contract Services Adds Commercial Gerteis Roller Compaction Capabilities
Oct 26, 2018
Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio
Jul 09, 2018
HedgePath Pharmaceuticals Closes Second Tranche of Mayne Pharma Financing
Jan 11, 2018
HedgePath Pharmaceuticals Secures New Funding from Mayne Pharma to Support BCCNS Clinical and Regulatory Approval Programs